Spinecap SAS’s KLA KLAC Stock Holding History

Spinecap SAS’s Portfolio KLAC Stock Details KLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-187,350	Closed	-$16.8M	–	15
2025 Q2	$16.8M	Buy	+187,350	New	+$14.1M	8.73%	4
2023 Q4	$1.74M	Buy	+30,000	New	+$1.56M	3.29%	7

Other funds holding KLAC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Spinecap SAS's KLAC Position: Q3 2025 in Review

Spinecap SAS sold out of KLA (KLAC) in Q3 2025, closing a stake of 187,350 shares — an estimated $16.8M sold.

Spinecap SAS first reported a position in KLAC in Q4 2023 and held it in 2 quarters. The position peaked at $16.8M in Q2 2025. 1,733 funds tracked by Wall St. Rank hold KLAC as of Q3 2025.

Spinecap SAS reported no remaining KLA position as of Q3 2025 after selling out during the quarter.
Spinecap SAS sold 187,350 KLA shares in Q3 2025, an estimated $16.8M.
Spinecap SAS first reported a position in KLA in Q4 2023 and held it in 2 quarters.
Spinecap SAS's KLA position peaked at $16.8M in Q2 2025.
1,733 funds tracked by Wall St. Rank held KLA as of Q3 2025.

Based on Spinecap SAS's 13F filing for Q3 2025, filed 19 Feb 2026.